Therapeutic Asset Ratings
436 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Eloxatin
Advanced Solid Tumors
Sixth Affiliated Hospital, Sun Yat-sen University
P4
BB
(66)
FLUOROURACILUM
Advanced Solid Tumors
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BB
(65)
CIS-DIAMMINEDICHLOROPLATINUM II
Advanced Solid Tumors
InSilico Medicine Hong Kong Limited
P4
BB
(64)
Calcium folinate pentahydrate
Advanced Solid Tumors
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BB
(64)
Irinotecan
Advanced Solid Tumors
Sixth Affiliated Hospital, Sun Yat-sen University
P3
BB
(64)
Carboplatin
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
P2/3
B
(63)
Docetaxel
Advanced Solid Tumors
InSilico Medicine Hong Kong Limited
P3
B
(62)
ETOPOSIDE
Advanced Solid Tumors
Nanjing Leads Biolabs Co.,Ltd
P3
B
(61)
Zoladex
Advanced Solid Tumors
OnKure, Inc.
P2/3
B
(61)
Osimertinib
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
P4
B
(60)
Axitinib
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(60)
(+)-VINCRISTINE
Advanced Solid Tumors
Sixth Affiliated Hospital, Sun Yat-sen University
P3
B
(60)
Fludarabine
Advanced Solid Tumors
National Cancer Institute (NCI)
P2
B
(60)
Fruquintinib
Advanced Solid Tumors
Fudan University
P2
B
(60)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Advanced Solid Tumors
CStone Pharmaceuticals
P2
B
(60)
Inno-206
Advanced Solid Tumors
Junpeng Wang
P3
B
(59)
PREDNISONE TABLETS
Advanced Solid Tumors
Exelixis
P3
B
(59)
Cetuximab
Advanced Solid Tumors
National Cancer Institute (NCI)
P3
B
(58)
Crizotinib
Advanced Solid Tumors
Canadian Cancer Trials Group
P3
B
(58)
Everolimus
Advanced Solid Tumors
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
P3
B
(58)
Itraconazole
Advanced Solid Tumors
Hansoh BioMedical R&D Company
P3
B
(58)
TIPIRACIL
Advanced Solid Tumors
Parabilis Medicines, Inc.
P3
B
(58)
TRASTUZUMAB
Advanced Solid Tumors
University Health Network, Toronto
P3
B
(58)
Trifluridine
Advanced Solid Tumors
Parabilis Medicines, Inc.
P3
B
(58)
Durvalumab
Advanced Solid Tumors
Inimmune Corporation
P2
B
(58)
Showing 1 to 25 of 436 assets
Previous
Page 1 of 18
Next
